L1CAM and non-small cell lung carcinoma: Otherwise, L1CAM appeared to be required for growth in vitro under inflammatory signaling, while its in vivo overexpression marked an increase in the prometastatic potential of NSCLC, despite the fact that this also appeared to extend the overall survival (Fig. 6, E and F).